Overview
Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2025-09-01
2025-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritisPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Alexandria University
Criteria
Inclusion Criteria:- Patients with mild to moderate disease activity.
- Patient age must be more than 18 years.
Exclusion Criteria:
- Pregnant and lactating females.
- Patients with liver, renal impairment or any other inflammatory diseases.
- Patients on TNF-α or IL-1β antagonists.